Get the Stockscreener App
1.70
12.37%
-0.24
After Hours:
1.71
0.01
+0.59%
Tela Bio Inc stock is traded at $1.70, with a volume of 112.65K.
It is down -12.37% in the last 24 hours and down -12.37% over the past month.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
See More
Previous Close:
$1.94
Open:
$1.9243
24h Volume:
112.65K
Relative Volume:
1.00
Market Cap:
$67.24M
Revenue:
$63.15M
Net Income/Loss:
$-40.30M
P/E Ratio:
-1.018
EPS:
-1.67
Net Cash Flow:
$-44.47M
1W Performance:
-12.82%
1M Performance:
-12.37%
6M Performance:
-35.61%
1Y Performance:
-61.80%
1-Day Range:
$1.69
$1.99
1-Week Range:
$1.69
$2.13
52-Week Range:
$0.8645
$4.46
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.70 | 76.74M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Tela Bio Inc Stock (TELA) Latest News
When is TELA Bio Inc. stock expected to show significant growthTop Growth Tips For Consistent Profits - jammulinksnews.com
What institutional investors are buying TELA Bio Inc. stockStock Strategy Recommendation From AI Tools - jammulinksnews.com
Will TELA Bio Inc. stock benefit from AI tech trendsDividend Strategy Summary With 10-Year Outlook - Newser
Intraday pattern recognizer results for TELA Bio Inc.Deep Stock Performance and Volatility Analysis - Newser
Price Channel Expanding on TELA Bio Inc.’s ChartReal Time Trade Opportunity Alerts Monitor Market Surges - metal.it
What indicators show strength in TELA Bio Inc.Free Access to Real-Time Trade Insights - Newser
TELA Bio (NASDAQ:TELA) Trading 4.2% Higher – Time to Buy? - Defense World
TELA Bio Inc. Price Targets Raised After ReboundReal Time Alerts Based on AI Prediction Triggered - metal.it
How TELA Bio Inc. stock performs during market volatilityLow Risk Trade Timing with Analysis Metrics - Newser
TELA Bio to Announce Q2 2025 Results with Live Webcast and Corporate Update - MSN
How many analysts rate TELA Bio Inc. as a “Buy”Invest confidently with proven investment plans - jammulinksnews.com
TELA Bio Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming Free High Conviction Intraday Stock Signals - metal.it
Published on: 2025-07-28 04:09:59 - jammulinksnews.com
What are the latest earnings results for TELA Bio Inc.Discover breakthrough investment opportunities - jammulinksnews.com
What are analysts’ price targets for TELA Bio Inc. in the next 12 monthsBeginner Investor Opportunities To Watch Now - jammulinksnews.com
Is TELA Bio Inc. stock overvalued or undervaluedRemarkably fast returns - jammulinksnews.com
why tela bio inc. stock attracts strong analyst attentionInvestor Favorite Picks - Newser
Is TELA Bio Inc. Stock Overbought or Oversold RSI Indicator AnalysisStrategic High Profit Opportunities - Newser
TELA Bio to Present at Canaccord Genuity 45th Annual Growth Conference - MSN
What analysts say about TELA Bio Inc. stockExponentially increasing returns - Autocar Professional
What risks could impact TELA Bio Inc. stock performanceOutstanding capital returns - jammulinksnews.com
TELA Bio Inc. Stock Analysis and ForecastSky-high return potential - PrintWeekIndia
What institutions are buying TELA Bio Inc. stock nowFree Stock Market Beginners Guide - jammulinksnews.com
What drives TELA Bio Inc. stock priceSky-high profits - PrintWeekIndia
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference - GlobeNewswire
TELA Bio Soft-Tissue Tech Showcase: Key Investor Presentation Coming August 13 at Canaccord Conference - Stock Titan
Is TELA Bio Inc. a good long term investmentMarket-leading growth rates - jammulinksnews.com
TELA Bio to Announce Second Quarter 2025 Financial Results - GlobeNewswire
Medical Tech Leader TELA Bio Sets Q2 Earnings Date: Key Financial Results Coming August 11 - Stock Titan
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):